November 18, 2022

Dear All, belows are this week’s headlines!

1，FDA Issues (More) Meaningless Warning Letters
(FDA doesn’t regulate Chinese manufacturers, so why warn them?)

FDA Issues (More) Meaningless Warning Letters

2，New Zealand’s Vape Importers Are Warned Over Nicotine Level Limits
(Importers and manufacturers of vaping products in New Zealand are being warned to review the nicotine concentrations of their products, or risk having them withdrawn if they exceed limits.)

New Zealand’s Vape Importers Are Warned Over Nicotine Level Limits

3，Australia: NSW Anti-Vape Campaign Should be Fact Checked
The ‘Get the Facts’ – Vaping Toolkit’campaign does not contain evidence based scientific facts

Australia: NSW Anti-Vape Campaign Should be Fact Checked

4，Altria Has Been Developing New Alternative Nicotine Products
(Tobacco giant Altria Group Inc. is expecting to finalize development work on two novel nicotine products by the end of this year.)

Altria Has Been Developing New Alternative Nicotine Products 

5，China: Consumption Vape Tax to go Into Effect This November
(The Ministry of Finance has approved a tax on vaping products which will go into effect on November 1st.)

China: Consumption Vape Tax to go Into Effect This November

6，Japan’s Tobacco Harm Reduction Efforts Are Working
(In Japan smoking rates are disappearing thanks to the increased use safer nicotine alternatives. )

Japan’s Tobacco Harm Reduction Efforts Are Working

7，Vape Group Files Amicus Brief Over Flavor Ban
(Supreme Court review is critical considering the nicotine industry’s economic impact, writes VTA.)

Vape Group Files Amicus Brief Over Flavor Ban

Editor’s Weekly Picks :

Australian Study Shows The Effectivity of Vaping For Smoking Cessation
(In line with data from across the globe, a 2019 study published in the journal Addiction, confirmed that vaping helped Australian smokers quit smoking.)

Australian Study Shows The Effectivity of Vaping For Smoking Cessation